Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 2 17Phase 3 4Phase 1/2 3Phase 1 3Phase 4 2Phase 2/3 2

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Liver Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Cisplatin 111Carboplatin 111pembrolizumab 109Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Radiofrequency Ablation × Clear all
NCT01853618 2019-12-10

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
61 enrolled 18 charts
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00891475 2014-02-13

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Kidney Cancer Research Bureau

Phase 1/2 Completed
114 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡